covishield
Jump to
13 Results Found
  • Dr Gagandeep Kang on Covishield 2nd dose & why plasma therapy isn’t good May 17, 2021 05:22 PM IST

    Dr Gagandeep Kang on Covishield 2nd dose & why plasma therapy isn’t good

    One of India's top vaccine experts Dr Gagandeep Kang spoke to Moneycontrol's Chandra R Srikanth on the Government's vaccination roadmap, why there should be central procurement, if it is advisable to take the second dose of Covishield after 12 weeks and why plasma therapy should be dropped. She also spoke about when the second wave of Coronavirus began to taper in India.

  • Covid vaccine production and availability: What we know so far May 04, 2021 02:23 PM IST

    Covid vaccine production and availability: What we know so far

    So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.

  • Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors? Apr 22, 2021 10:14 AM IST

    Take a jab! 12 healthcare stocks hit fresh 52-week high; huge opportunity for long term investors?

    The year that started out on a sizzling note has fizzled out, with only the pharma sector - naturally - emerging as the top performer, quite like 2020

  • COVID-19 update | Covishield comprises over 90% of 12.76 crore vaccines administered so far Apr 21, 2021 05:08 PM IST

    COVID-19 update | Covishield comprises over 90% of 12.76 crore vaccines administered so far

    Of this, 15 states and union territories have only given Covishield, being manufactured by the Pune-based Serum Instiute of India.

  • COVID-19 vaccine | Serum Institute's Covishield priced at Rs 400 per dose for states; Rs 600/dose for private hospitals Apr 21, 2021 12:42 PM IST

    COVID-19 vaccine | Serum Institute's Covishield priced at Rs 400 per dose for states; Rs 600/dose for private hospitals

    Serum Institute of India said 50 percent of its capacities will serve the Centre's COVID-19 vaccination programme, and the remaining 50 percent will be for state governments and private hospitals.

  • UP man gets Covaxin shot as first dose, Covishield as second Apr 19, 2021 11:44 AM IST

    UP man gets Covaxin shot as first dose, Covishield as second

    The UP CMO has ordered the suspension of the health worker till the investigation is complete.

  • Increase Covishield dose gap to 6-8 weeks, Centre tells states Mar 22, 2021 03:56 PM IST

    Increase Covishield dose gap to 6-8 weeks, Centre tells states

    This time interval between two doses has been revised only for Covishield and not Covaxin.

  • What India plans to do with Covishield, the AstraZeneca COVID-19 vaccine suspended by several countries? Mar 16, 2021 01:02 PM IST

    What India plans to do with Covishield, the AstraZeneca COVID-19 vaccine suspended by several countries?

    The World Health Organization has insisted the AstraZeneca shot is safe, and that there is no link between the vaccine and reported blood clots.

  • Covishield vs Covaxin: A comparison of COVID-19 vaccines administering in India Mar 01, 2021 10:28 AM IST

    Covishield vs Covaxin: A comparison of COVID-19 vaccines administering in India

    India has approved two vaccines—Covaxin developed by Hyderabad-based Bharat Biotech and Covishield from the Oxford-AstraZeneca stable being manufactured by the Serum Institute of India —for emergency use in the country.

  • 5 die in Serum Institute of India fire in Pune; no impact on Covishield Jan 21, 2021 03:25 PM IST

    5 die in Serum Institute of India fire in Pune; no impact on Covishield

    CEO Adar Poonawalla said equipment worth hundreds of crores were damaged in the fire, and the company is expected to face revenue loss of more than Rs 1,000 crore over the next one to two years.

  • PM Narendra Modi to launch CoWin app on January 16, virtually kickoff India's vaccination drive Jan 13, 2021 03:25 PM IST

    PM Narendra Modi to launch CoWin app on January 16, virtually kickoff India's vaccination drive

    Around three crore frontline workers, including one crore medics, are scheduled to be inoculated in the first phase.

  • COVID-19 vaccine | Serum's Covishield, Bharat Biotech's Covaxin 'not considered' for emergency use authorisation: Sources Dec 09, 2020 05:51 PM IST

    COVID-19 vaccine | Serum's Covishield, Bharat Biotech's Covaxin 'not considered' for emergency use authorisation: Sources

    Both Bharat Biotech and Serum Institute of India have been asked by the Subject Expert Committee to furnish more data, trial information, and documents

  • Big Story | Serum Institute to seek Rs 100 crore In damages from vaccine volunteer: A look at Covishield legal row Nov 30, 2020 05:37 PM IST

    Big Story | Serum Institute to seek Rs 100 crore In damages from vaccine volunteer: A look at Covishield legal row

    The 40-year-old volunteer claimed that he contracted severe neurological disorders after being vaccinated with Covidshield shots under development at Serum Institute of India. All you need to know about the legal hassle.

Sections